IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Amyloid Beta: The Foremost Protagonist in Alzheimer's Disease

Amyloid Beta: The Foremost Protagonist in Alzheimer's Disease
View Sample PDF
Author(s): Abhinav Anand (Lovely Professional University, India), Neha Sharma (Lovely Professional University, India), Monica Gulati (Lovely Professional University, India)and Navneet Khurana (Lovely Professional University, India)
Copyright: 2019
Pages: 17
Source title: Handbook of Research on Critical Examinations of Neurodegenerative Disorders
Source Author(s)/Editor(s): Md. Sahab Uddin (Southeast University, Bangladesh)and Md. Shah Amran (University of Dhaka, Bangladesh)
DOI: 10.4018/978-1-5225-5282-6.ch011

Purchase

View Amyloid Beta: The Foremost Protagonist in Alzheimer's Disease on the publisher's website for pricing and purchasing information.

Abstract

Alzheimer's disease (AD), exhibiting accumulation of amyloid beta (Aβ) peptide as a foremost protagonist, is one of the top five causes of deaths. It is a neurodegenerative disorder (ND) that causes a progressive decline in memory and cognitive abilities. It is characterized by deposition of Aβ plaques and neurofibrillary tangles (NFTs) in the neurons, which in turn causes a decline in the brain acetylcholine levels. Aβ hypothesis is the most accepted hypothesis pertaining to the pathogenesis of AD. Amyloid Precursor Protein (APP) is constitutively present in brain and it is cleaved by three proteolytic enzymes (i.e., alpha, beta, and gamma secretases). Beta and gamma secretases cleave APP to form Aβ. Ubiquitin Proteasome System (UPS) is involved in the clearing of Aβ plaques. AD also involves impairment in UPS. The novel disease-modifying approaches involve inhibition of beta and gamma secretases. A number of clinical trials are going on worldwide with moieties targeting beta and gamma secretases. This chapter deals with an overview of APP and its enzymatic cleavage leading to AD.

Related Content

Katie Moraes de Almondes, Gilberto Sousa Alves, Candida Lopes Alves. © 2024. 16 pages.
Jonathan Araujo Queiroz, Gean Sousa, Priscila Lima Rocha, Yonara Costa Magalhões, Allan Kardec Barros Filho. © 2024. 19 pages.
Givago Silva Souza, Brena Karoline Ataíde Furtado, Edilson Brabo Almeida, Bianca Callegari, Maria da Conceição Nascimento Pinheiro. © 2024. 15 pages.
Jonathan Araujo Queiroz, Juliana M. Silva, Yonara Costa Magalhães, Will Ribamar Mendes Almeida, Bárbara Barbosa Correia, José Ricardo Santo de Lima, Edilson Carlos Silva Lima, Marcos Jose Dos Passos Sa, Allan Kardec Barros Filho. © 2024. 14 pages.
Walter Barbalho Soares, Amannda Melo de Oliveira Lima. © 2024. 23 pages.
Gilberto Sousa Alves, Romulo Kunrath Pinto Silva, Marielia Barbosa Freitas Leal, Bianca de Melo Ferro, Leandro de Oliveira Trovão. © 2024. 20 pages.
Felippe Mendonca, Paulo Mattos, Felipe Kenji Sudo. © 2024. 18 pages.
Body Bottom